checkAd
    Ambrx Biopharma Incorporation Aktie
    13,000
     
    USD
    -4,90 %
    -0,670 USD
    Letzter Kurs 12.10.23 Nasdaq
    13,520
     
    USD
    100 STK
    Geldkurs 12.10.23
    13,680
     
    USD
    100 STK
    Briefkurs 12.10.23
    ISIN: US02290A1025 · WKN: A3CSHW · SYM: AMAM · Kaiman-Inseln

    Neueste Nachrichten

    Ambrx Shareholders Approve Acquisition by Johnson & Johnson
    06.03.24 · globenewswire · Ambrx Biopharma Incorporation
    AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM
    10.02.24 · Business Wire (engl.) · Ambrx Biopharma Incorporation
    AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM
    10.01.24 · Business Wire (engl.) · Ambrx Biopharma Incorporation
    AMAM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Ambrx Biopharma, Inc. Is Fair to Shareholders
    08.01.24 · Business Wire (engl.) · Ambrx Biopharma Incorporation
    Ambrx Announces Sale to Johnson & Johnson
    08.01.24 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)
    14.12.23 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx Provides Update On APEX-01, an On-Going Phase 1 / 2 Dose Escalation Study Evaluating ARX517, a Proprietary PSMA-Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
    28.11.23 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx Announces ARX517, a PSMA-Targeted ADC, Demonstrates a Promising 52% PSA50 (≥50% Reduction) and a Highly Differentiated Safety and PK Profile in Patients with mCRPC, who Progressed on Multiple FDA-Approved Treatments
    23.10.23 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress
    16.10.23 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx to Host KOL Event Discussing ARX517 Data Presented at ESMO Congress 2023
    26.09.23 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx to Participate in the Cantor Fitzgerald Global Healthcare Conference
    18.09.23 · globenewswire · Ambrx Biopharma Incorporation
    Ambrx to Present at the Baird and Morgan Stanley Global Healthcare Conferences
    05.09.23 · globenewswire · Ambrx Biopharma Incorporation